Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Celldex Therapeutics, Inc. (CLDX)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5M | $7.0M | $6.9M | $2.4M | $4.7M | $7.4M | $3.6M | $9.5M | $12.7M | $6.8M | $5.5M | $3.6M | $4.1M | $11.2M | $9.3M | $46.8M | $15.2M |
| Research & development | $245.1M | $163.6M | $118.0M | $82.3M | $53.3M | $42.5M | $42.7M | $66.4M | $96.2M | $102.7M | $100.2M | $104.4M | $67.4M | $47.4M | $32.4M | $27.6M | $26.2M |
| Operating income | −$287.4M | −$195.1M | −$154.5M | −$115.2M | −$71.2M | −$63.4M | −$55.0M | −$156.4M | −$121.5M | −$132.9M | −$129.5M | −$122.4M | −$81.4M | −$58.1M | −$43.4M | −$6.5M | −$36.9M |
| EBITDAderived | −$284.0M | −$191.9M | −$151.5M | −$112.3M | −$68.2M | −$59.4M | −$50.2M | −$152.9M | −$117.1M | −$129.8M | −$126.5M | −$120.0M | −$79.5M | −$56.0M | −$41.2M | −$3.7M | −$34.3M |
| Net income | −$258.8M | −$157.9M | −$141.4M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic EPSper diluted share | -$3.90 | -$2.45 | -$2.92 | -$2.40 | -$1.64 | -$2.02 | -$3.51 | -$14.48 | -$10.86 | -$18.99 | -$1.31 | -$1.32 | -$1.02 | -$1.02 | -$1.13 | -$0.08 | -$1.84 |
| Diluted EPSper diluted share | -$3.90 | -$2.45 | -$2.92 | -$2.40 | -$1.64 | -$2.02 | -$3.51 | -$14.48 | -$10.86 | -$18.99 | -$1.31 | -$1.32 | -$1.02 | -$1.02 | -$1.13 | -$0.08 | -$1.84 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 4, 2025Form 4 | Jimenez Freddy A.SVP & GENERAL COUNSEL | SellCommon Stock | 4.2K | $29.10 | $121.2K | 30.8K |
| Nov 13, 2025Form 4 | Wright Richard M.Other | SellCommon Stock | 49.3K | $24.00 | $1.18M | 20.8K |
| Aug 13, 2025Form 4 | Jimenez Freddy A.SVP & GENERAL COUNSEL | SellCommon Stock | 430 | $25.42 | $10.9K | 35.0K |
| Aug 13, 2025Form 4 | Jimenez Freddy A.SVP & GENERAL COUNSEL | SellCommon Stock | 341 | $23.95 | $8.2K | 35.4K |
| Nov 11, 2024Form 4 | Marucci Anthony SPRESIDENT & CEO | BuyCommon Stock | 11.5K | $26.82 | $308.4K | 40.3K |